We determined that LSD1’s catalytic function appears to be dispensable for repressing TP53 signaling and promoting NEPC cell survival, and LSD1 inhibition with RNA interference (RNAi) or an allosteric LSD1 inhibitor reduces NEPC tumor growth in vivo. The gene discussed is KDM1A; the disease is neoplasm.